Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum heme polymerization process is a critical detoxification mechanism employed by the malaria parasite during its intraerythrocytic developmental stage (Sullivan, 2002). As the parasite degrades host hemoglobin to acquire essential amino acids, it releases large quantities of free heme (ferriprotoporphyrin IX), which is highly toxic due to its ability to generate reactive oxygen species and destabilize cellular membranes (Hempelmann, 2007). To survive, the parasite converts this toxic heme into an insoluble, chemically inert crystalline pigment called hemozoin (Egan, 2008). This process takes place within the parasite's acidic digestive vacuole and is the primary target for several classes of antimalarial drugs, most notably the 4-aminoquinolines and quinoline methanols (Weissbuch & Leiserowitz, 2008). Drugs like chloroquine interfere with this pathway by forming complexes with heme or capping the growing hemozoin crystals, thereby preventing further polymerization and causing the accumulation of toxic heme, which ultimately leads to parasite death (Fidock et al., 2000). However, the clinical utility of targeting this process is increasingly threatened by the widespread development of resistance, often mediated by mutations in the PfCRT transporter (Wellems & Plowe, 2001).
Inhibition of the biocrystallization of toxic free heme into inert hemozoin, leading to the accumulation of ferriprotoporphyrin IX which causes oxidative damage and parasite death (Egan, 2008; Weissbuch & Leiserowitz, 2008).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum heme polymerization process.